Retinal Vein Occlusion Market Size is Expected to Reach US$ 32.5 Billion and Growing at 7.3% CAGR by 2031

According to the report, the global retinal vein occlusion market was valued at US$ 15.6 Bn in 2020 and is Expected to Reach US$ 32.5 Billion at a CAGR of 7.3% from 2021 to 2031. Retinal vein occlusion is the blockage of the retinal vein due to blood clot. Retinal vein occlusion is the second most common cause of visual impairment globally. A blood clot causes a blockage in the vein, which starts draining blood from retina, resulting in swelling and bleeding, affecting the vision of the person. Rise in prevalence of eye diseases globally, increase in the geriatric population, surge in awareness about eye disorders, improved healthcare infrastructure, technological advancements, and upcoming novel treatments are the major drivers of the global retinal vein occlusion market.

North America held major share of the global retinal vein occlusion market in 2020 due to improved healthcare infrastructure, rise in prevalence of eye diseases, advanced technology, and increase in the geriatric population. The retinal vein occlusion market in Asia Pacific is likely to expand at a high CAGR of 9.7% from 2021 to 2031. Increase in incidence of eye diseases in Asia Pacific, especially in China, Singapore, Indonesia, and other countries in Southeast Asia, and rise in healthcare expenditure are expected to fuel the growth of the market in Asia Pacific from 2021 to 2031.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 & 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 𝐚𝐭 (𝐔𝐬𝐞 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐞 𝐌𝐚𝐢𝐥 𝐈𝐝 𝐟𝐨𝐫 𝐐𝐮𝐢𝐜𝐤 𝐑𝐞𝐬𝐩𝐨𝐧𝐬𝐞) - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=60489

𝐂𝐞𝐧𝐭𝐫𝐚𝐥 𝐑𝐞𝐭𝐢𝐧𝐚𝐥 𝐕𝐞𝐢𝐧 𝐎𝐜𝐜𝐥𝐮𝐬𝐢𝐨𝐧 𝐒𝐞𝐠𝐦𝐞𝐧𝐭 𝐃𝐨𝐦𝐢𝐧𝐚𝐭𝐞𝐝 𝐆𝐥𝐨𝐛𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭

In terms of type, the global retinal vein occlusion market has been bifurcated into central retinal vein occlusion and branch retinal vein occlusion. The central retinal vein occlusion segment dominated the global retinal vein occlusion market in 2020, and the trend is projected to continue during the forecast period.

𝐀𝐧𝐭𝐢-𝐕𝐄𝐆𝐅 𝐃𝐫𝐮𝐠𝐬 𝐇𝐞𝐥𝐝 𝐌𝐚𝐣𝐨𝐫 𝐒𝐡𝐚𝐫𝐞 𝐨𝐟 𝐆𝐥𝐨𝐛𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭

Based on treatment type, the global retinal vein occlusion market has been classified into anti-VEGF drugs, corticosteroid drugs, pan-retinal photocoagulation therapy, and laser therapy. The anti-VEGF drugs segment held major share of the global retinal vein occlusion market in 2020. Rise in prevalence and incidence of diabetes drives the segment.

𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐭𝐨 𝐃𝐨𝐦𝐢𝐧𝐚𝐭𝐞 𝐆𝐥𝐨𝐛𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭; 𝐀𝐬𝐢𝐚 𝐏𝐚𝐜𝐢𝐟𝐢𝐜 𝐭𝐨 𝐎𝐟𝐟𝐞𝐫 𝐒𝐢𝐠𝐧𝐢𝐟𝐢𝐜𝐚𝐧𝐭 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬

In terms of region, the global retinal vein occlusion market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is anticipated to account for leading share of the global retinal vein occlusion market during the forecast period. The retinal vein occlusion market in Asia Pacific is projected to grow at a rapid pace in the near future. India and China are likely to be lucrative markets for retinal vein occlusion treatment during the forecast period.

𝐆𝐫𝐨𝐰𝐭𝐡 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬

Key players operating in the global retinal vein occlusion market are Alimera Sciences, Allergan (AbbVie, Inc.), Annexin Pharmaceuticals AB (publ), Bayer AG, Carl Zeiss AG, F. Hoffmann-La Roche Ltd., Iridex Corporation, Lumenis, Nidek Co., Ltd., Novartis AG, Regeneron Pharmaceuticals, Inc., and Topcon Corporation. The global retinal vein occlusion market is semi-consolidated with the presence of international and local players.

𝐆𝐫𝐨𝐰 𝐲𝐨𝐮𝐫 𝐩𝐫𝐨𝐟𝐢𝐭 𝐦𝐚𝐫𝐠𝐢𝐧 𝐰𝐢𝐭𝐡 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 - 𝐁𝐮𝐲 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭! https://www.transparencymarketresearch.com/checkout.php?rep_id=60489&ltype=S

𝐆𝐥𝐨𝐛𝐚𝐥 𝐑𝐞𝐭𝐢𝐧𝐚𝐥 𝐕𝐞𝐢𝐧 𝐎𝐜𝐜𝐥𝐮𝐬𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧

𝐑𝐞𝐭𝐢𝐧𝐚𝐥 𝐕𝐞𝐢𝐧 𝐎𝐜𝐜𝐥𝐮𝐬𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭, 𝐛𝐲 𝐓𝐲𝐩𝐞
Central Retinal Vein Occlusion
Branch Retinal Vein Occlusion

𝐑𝐞𝐭𝐢𝐧𝐚𝐥 𝐕𝐞𝐢𝐧 𝐎𝐜𝐜𝐥𝐮𝐬𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭, 𝐛𝐲 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐓𝐲𝐩𝐞
Anti-VEGF Drugs
Corticosteroid Drugs
Pan-retinal Photocoagulation Therapy
Laser Therapy

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 -

𝐒𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐑𝐨𝐛𝐨𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 - https://www.prnewswire.com/news-releases/surgical-robots-market-to-exceed-us-25-bn-by-2031-rapid-adoption-of-medical-robotic-systems-in-minimally-invasive-surgeries-to-propel-revenue-growth-tmr-study-301564735.html

𝐓𝐚𝐮𝐫𝐢𝐧𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 - https://www.globenewswire.com/news-release/2022/04/05/2416932/0/en/Taurine-Market-to-Expand-at-CAGR-of-7-9-During-Forecast-Period-Observes-TMR-Study.html

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453